CD4 and neoplasm: We here showed that the effective T cells, including CD4+T, CD8+T and Tprolif in tumor tissues have higher levels of cuproptosis than T cells from PBMCs of tumor patients (Figure 3C), illustrating that the reduction of effective T cells within tumor tissues might be caused by cuproptosis.